Isofol Medical CFO and Deputy CEO Gustaf Albèrt to step down during 2023
GOTHENBURG, Sweden, December 21, 2022 – Isofol Medical AB (publ) announced today that Chief Financial Officer (CFO) Gustaf Albèrt, who has held the position since 2017 and since 2019 has also served as the company’s deputy CEO, has together with Isofol agreed to end his employment.The information in the press release is intended for investors. Gustaf Albèrt and Isofol have today come to an agreement that Gustaf will step down from his position as CFO and deputy CEO of Isofol Medical. The notice period will last until June 20, 2023 at the latest and during this time Gustaf will continue